Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 14, Issue 21, Pages 4853-4858Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ob00803h
Keywords
-
Categories
Funding
- EU
- Ligue contre le Cancer (Comite des Pyrenees-Orientales)
Ask authors/readers for more resources
JNJ-26990990 ((benzo[b]thien-3-yl)methyl)sulfamide, a sulfamide derivative structurally related to the antiepileptic drug zonisamide, was reported to be devoid of carbonic anhydrase (CA, EC 4.2.1.1) inhibitory properties. Here we report that JNJ-26990990 and its S,S-dioxide analog significantly inhibit six human (h) isoforms, hCA I, II, VII, IX, XII and XIV, involved in crucial physiological processes. Inhibition and X-ray crystallographic data for the binding of the two compounds to these enzymes show significant similarity with the zonisamide inhibitory pattern. These findings prompted us to reconsider the structural/pharmacological requirements for designing effective antiepileptics possessing zinc-binding groups of the sulfamide, sulfamate or sulfonamide type in their molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available